Nobuo Funao
Impact in
- Gastroenterology top 1%
- Gastroesophageal reflux and treatments
- Surgery top 5%
- Helicobacter pylori-related gastroenterology studies
- Eosinophilic Esophagitis
- Gastrointestinal disorders and treatments
Papers in
- Surgery 11
- Helicobacter pylori-related gastroenterology studies 8
- Eosinophilic Esophagitis 6
- Esophageal and GI Pathology 2
-
- Gastroesophageal reflux and treatments 8
- Co-authors
- Akira Nishimura (7 shared papers)Madoka Shiino (2 shared papers)Yuuichi Sakurai (4 shared papers)Kazunari Murakami (2 shared papers)Masahiro Asaka (2 shared papers)Takashi Kawai (5 shared papers)Yuji Mizokami (5 shared papers)Kazunori Oda (5 shared papers)
- Journals
- Gastroenterology (6 papers)Gut (4 papers)The Lancet Diabetes & Endocrinology (1 paper)Chinese Medical Journal (1 paper)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Nobuo Funao
12 papers receiving 644 citations
Nobuo Funao's Hit Papers
Peers
Comparison fields: 5 of 61
- Gastroenterology 428
- Surgery 542
- Small Animals 74
- Pulmonary and Respiratory Medicine 226
- Pharmacology 41
Countries citing papers authored by Nobuo Funao
This map shows the geographic impact of Nobuo Funao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Funao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Funao more than expected).
Fields of papers citing papers by Nobuo Funao
This network shows the impact of papers produced by Nobuo Funao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Funao. The network helps show where Nobuo Funao may publish in the future.
Co-authors
The 25 scholars most cited alongside Nobuo Funao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study Hit paper breakdown → | 2016 | 319 |
| 2 | 2019 | 89 | |
| 3 | 2017 | 85 | |
| 4 | 2017 | 82 | |
| 5 | 2013 | 43 | |
| 6 | 2024 | 8 | |
| 7 | 2014 | 8 | |
| 8 | 2014 | 8 | |
| 9 | 2014 | 7 | |
| 10 | 2020 | 2 | |
| 11 | 2015 | 1 | |
| 12 | 2018 | 1 |
About Nobuo Funao
Nobuo Funao is a scholar working on Surgery, Gastroenterology, Pharmacology, Cardiology and Cardiovascular Medicine and Family Practice, having authored 12 papers that have together received 653 indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (8 papers), Gastroesophageal reflux and treatments (8 papers), Eosinophilic Esophagitis (6 papers), Inflammatory mediators and NSAID effects (3 papers), Esophageal and GI Pathology (2 papers), Gastric Cancer Management and Outcomes (1 paper), Peptidase Inhibition and Analysis (1 paper) and Microscopic Colitis (1 paper). The work is most often cited by research in Gastroenterology (428 citations), Surgery (542 citations), Small Animals (74 citations), Pulmonary and Respiratory Medicine (226 citations) and Pharmacology (41 citations). Nobuo Funao has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Akira Nishimura, Madoka Shiino, Yuuichi Sakurai, Kazunari Murakami, Masahiro Asaka, Takashi Kawai, Yuji Mizokami, Kazunori Oda, Kiyoshi Ashida and Kentaro Sugano. Their work appears in journals such as Gastroenterology, Gut, The Lancet Diabetes & Endocrinology and Chinese Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.